Table 3. Examples of Clinical Rating Scales
| Scale | Administration (Time) | Clinical Use | Reference | Availability |
|---|
|
Quality of
life
|
|
Quality of Life Enjoyment & Satisfaction Questionnaire
(Q-LES-Q)
|
Self-administered questionnaire; short (16-item; 5
min) or long (60-item; 15 min) format
|
Assessment of degree of enjoyment and satisfaction in
various areas of daily life
|
Endicott J, Nee J, Harrison W, et al: Quality of Life Enjoyment
and Satisfaction Questionnaire: a new scale. Psychopharmacol
Bull 29:321–326, 1993
|
Jean Endicott, Ph.D.; Dept. of Research Assessment
and Training, New York State Psychiatric Institute, Unit 123; 1051
Riverside Drive; New York, NY 10032; ph 212-543-5536
|
|
Mental health
status and functioning
|
| Clinical Global Impression (CGI) Scale |
Clinician-rated scale (1–2 min after clinical information
is obtained)
| Global assessment of response to medication treatment |
Guy W, Bonato RR (eds): Manual for the ECDEU Assessment
Battery, revised 2nd ed. Chevy Chase, Md, National Institute
of Mental Health, 1970, pp 12.1–12.6
|
Guy W: ECDEU Assessment Manual for Psychopharmacology, revised
ed. Washington, DC, US Department of Health, Education, and Welfare,
1976; APA (2000) Handbook of Psychiatric Measures |
| Global Assessment of Functioning (GAF) Scale |
Clinician-rated scale, ranked 0–100 (1–2 min
after clinical information is obtained)
|
Assessment of patient functioning, monitoring
of change, and selection of patients suitable for short-term treatment
| American Psychiatric Association: DSM-IV-TR | DSM-IV-TR |
|
Social and Occupational Functioning Assessment Scale
(SOFAS)
|
Clinician-rated scale, ranked 0–100 (1–2 min
after clinical information is obtained)
|
Assessment of patient social and occupational functioning
and monitoring of change
| American Psychiatric Association: DSM-IV-TR | DSM-IV-TR |
| Adverse effects |
| Abnormal Involuntary Movement Scale (AIMS) | Observer-rated 12-item anchored scale (5–10 min) |
Assessment of patients who may have involuntary movement
disorders (from antipsychotic medications) and
may have tardive dyskinesia
|
Guy W (ed): ECDEU Assessment Manual for Psychopharmacology, revised
ed. DHEW Publ No ADM 76-338. Washington, DC, US Department of Health,
Education, and Welfare, 1976
|
Guy 1976; APA (2000) Handbook of Psychiatric Measures |
|
Rating Scale for Extrapyramidal Side Effects or Simpson-Angus
Extrapyramidal Symptom Rating Scale
| Observer-rated 10-item anchored scale (10 min) |
Assessment of dose-limiting side effects when antipsychotic
medications are initiated, titrated, and monitored and effectiveness
of anticholinergic or other agents in the treatment of extrapyramidal
side effects
|
Simpson GM, Angus JWS: A rating scale for extrapyramidal
side effects. Acta Psychiatr Scand Suppl 1970; 212:11–19
|
APA (2000) Handbook of Psychiatric Measures |
|
Cognitive
disorders
|
| Delirium Rating Scale Revised–98 (DRS–R98) |
Clinician-administered structured exam (15–30
min)
|
Assessment of a broad range of delirium symptoms: the 16-item
scale can be used to diagnose delirium; the 13-item severity subscale can
be used to rate symptom severity
|
Trzepacz PT et al: Validation of the Delirium Rating ScaleRevised–98: comparison
with the Delirium Rating Scale and the Cognitive Test for Delirium.
J Neuropsychiatry Clin Neurosci 2001; 13:229–242;
erratum, 2001; 13:433
|
© Paula T. Trzepacz, M.D., Lilly Research Laboratories,
Indianapolis, IN 46285; PTT@lilly.com
|
| Mini-Mental State Examination (MMSE) |
Clinician-administered 30-item structured scale (5–10
min)
|
Detecting and tracking the progression of cognitive impairment
associated with neurogenerative diseases
|
Folstein MF et al: "Mini-Mental State":
a practical method for grading the cognitive state of patients for
the clinician. J Psychiatr Res 1975; 12:189–198
|
Administrator of the Mini-Mental LLC, 31 St. James Avenue,
Suite 1, Boston, MA 02116; ph 617-587-4215; APA (2000)
Handbook
of Psychiatric Measures
|
|
Alcohol use
disorders
|
| CAGE Questionnaire |
Self-report or observer-rated 4-item questionnaire
(<1 min)
| Screening for alcohol problems |
Ewing JA: Detecting alcoholism: The CAGE questionnaire.
JAMA 1984; 252: 1905–1907
|
APA (2000) Handbook of Psychiatric Measures |
| Mood disorders |
| Beck Depression Inventory, 2nd Revision (BDI-II) |
Self-report or observer-rated 21-item questionnaire,
ranked on a 0–3 scale (5–10 min)
|
Assessment of severity of depressive symptoms in patients
with diagnosed depressive illness and monitoring of treatment effects
|
Beck AT et al: An inventory for measuring depression. Arch
Gen Psychiatry 1961; 4:561–571
|
Harcourt Assessment, Inc., 19500 Bulverde Road, San Antonio,
TX 78259; ph 800-211-8378; http://harcourtassessment.com/haiweb/Cultures/en-US/default.htm |
| Hamilton Depression Rating Scale (Ham-D) |
Observer-rated 21- or 17-item checklist, ranked on
a 0–4 or 0–2 scale (15–20 min)
|
Assessment of severity of depressive symptoms in patients
with primary depressive illness and monitoring changes with treatment
|
Hamilton M: A rating scale for depression.
J Neurol Neurosurg Psychiatry 1960; 23:56–62
|
Guy W: ECDEU Assessment Manual for Psychopharmacology, revised
ed. DHEW Publ No ADM 76-338. Washington, DC, US Department of Health,
Education, and Welfare, 1976
|
|
Quick Inventory of Depression SymptomatologySelf-Report
(QIDS-SR)
|
Self-report 16-item scale including the nine domains
of major depressive disorder (5–7 min)
|
Assessment of depressive symptom severity and symptomatic
changes in a time efficient manner to gauge effects of treatment
|
Rush AJ et al: The 16-Item Quick Inventory of Depressive Symptomatology
(QIDS), Clinician Rating (QIDS-C), and Self-Report (QIDS-SR): a
psychometric evaluation in patients with chronic major depression. Biol
Psychiatry 2003; 54:573–583; erratum, 2003; 54:585
|
Trivedi MH et al: The Inventory of Depressive Symptomatology,
Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick
Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C)
and Self-Report (QIDS-SR) in public sector patients with
mood disorders, a psychometric evaluation. Psychol Med 2004; 34:73–82
|
| Patient Health Questionnaire (PHQ-9) |
Self-report, clinician-scored 9-item questionnaire
ranked on 0–3 scale and scored 0–27 (<2 min)
|
Assessment of DSM-IV depressive disorder diagnoses
and grading of depressive symptom severity
| http://www.pfizer.com/pfizer/phq-9/index.jsp |
Copyright 1999 Pfizer, Inc. http://www.pfizer.com/pfizer/phq-9/index.jsp; http://www.depressionprimarycare.org/clinicians/toolkits/materials/ |
| Geriatric Depression Scale (GDS) | Self-report 30-item scale (10–15 min) |
Screening for depressive illness in geriatric patients, assessment
of severity, and monitoring change with treatment
|
Yesavage JA et al: Development and validation of a
geriatric depression screening scale: a preliminary report. J Psychiatr
Res 1982; 17:37–49
|
Yesavage et al. 1982; APA (2000)
Handbook
of Psychiatric Measures
|
| Young Mania Rating Scale (YMRS) |
Clinician-administered 11-item checklist, ranked on
a 0–4 or 0–8 scale (15–30 min)
|
Assessment of the severity of mania and evaluation
of changes in manic symptoms with treatment over time
|
Young RC et al: A rating scale for mania: reliability, validity
and sensitivity. Br J Psychiatry 1978; 133:429–435
|
Young et al 1978; APA (2000)
Handbook
of Psychiatric Measures
|
| Anxiety disorders |
| Hamilton Anxiety Rating Scale (HARS) |
Clinician-administered 14-item scale, with items ranked
0–5 (15–30 min)
|
Assessment of the severity of overall anxiety in patients with
diagnosed anxiety or depressive disorders and monitoring outcome
of treatment
|
Hamilton M: The assessment of anxiety states by rating. Br
J Med Psychol 1959; 32:50–55
|
Hamilton 1959; Anxiety Disorders Prevention Program,
Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Pittsburgh,
PA 15213
|
| Yale-Brown Obsessive Compulsive Scale (Y-BOCS) |
Clinician-administered semistructured interview (30
min initially)
|
Assessment of overall obsessive-compulsive disorder
severity and monitoring change with treatment
|
Goodman WK et al: The Yale-Brown Obsessive Compulsive
Scale, I: development, use, and reliability. Arch Gen Psychiatry
1989; 46:1006–1011
|
University of Florida, College of Medicine, Department
of Psychiatry, P.O. Box 100256, 1600 SW Archer Road, Gainesville,
FL 32610; APA (2000) Handbook of Psychiatric Measures |
|
Psychotic
disorders
|
| Brief Psychiatric Rating Scale (BPRS) |
Clinician-rated 18-item scale, ranked 1–7
(20–30 min)
|
Global assessment of response to treatment in patients
with moderate to severe psychotic disorders
|
Overall JE, Gorham DR: The Brief Psychiatric Rating Scale:
recent developments in ascertaining and scaling. Psychopharmacol
Bull 1988; 24:97–99
|
Overall and Gorham, http://www.psychrehab.com; APA
(2000) Handbook of Psychiatric Measures |
| Positive and Negative Syndrome Scale (PANSS) |
Clinician-rated 3-subscale, 5-factor, 30-item scale
rated based on information from a structured interview (30–40
min) and informant information
|
Assessment of severity of common symptoms
in patients with schizophrenia and other psychotic disorders, delineation
of target symptoms, and monitoring of treatment response
|
Kay SR et al: Positive and Negative Syndrome Scale (PANSS)
Rating Manual. Toronto, ON, Multi-Health Systems, 2000
|
Multi-Health Systems, Inc., P.O. Box 950, North Tonawanda,
NY 14120-0950; ph 800-456-3003; fax 888-540-4484; http://www.mhs.com |
|
Aggression
and agitation
|
| Overt Aggression ScaleModified (OAS-M) |
Clinician-administered 25-item scale with 9 subscales
and rating three areas, aggression, irritability, and suicidality
(30 min)
|
Assessment of aggressive behaviors, delineation of target
symptoms, and monitoring of change over time
|
Coccaro E et al: Development of neuropharmacologically based behavioral assessments
of impulsive behavior. J Neuropsychiatry Clin Neurosci
1991; 3(suppl):S44–S51
|
Emil Coccaro, M.D., Department of Psychiatry, Medical
College of Pennsylvania, Eastern Pennsylvania Psychiatric Institute,
3200 Henry Avenue, Philadelphia, PA 19129; APA (2000)
Handbook
of Psychiatric Measures
|
| Source. Information
in this table was derived from APA's
Handbook
of Psychiatric Measures
(118).
|